Rash is the most common side effect of cancer immunotherapies, but patients should watch for more serious issues.
Michael A. Postow
Advertisement
Articles by Michael A. Postow
Advertisement
Latest Updated Articles
- Seeing Red
July 27th 2015
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Welireg Plus Keytruda Combination for Adjuvant Treatment of Renal Cell Carcinoma
2
From "Not Curable" to "May Be Curable": Joshua Richter, MD, on the New Reality of Multiple Myeloma
3
A CAR-T Therapy Is Working Better Than Expected for Patients With Hard to Treat Leukemia
4
Your Tumor's Genetic Profile May Not Change Which Treatment Works Best for TNBC
5